AKOYA BIOSCIENCES INC (AKYA) Stock Analyst Ratings
NASDAQ:AKYA - Nasdaq - US00974H1041 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 52% to AKYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.05. This target is 147.95% above the current price.
AKYA was analyzed by 13 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about AKYA.
In the previous month the buy percentage consensus was at a similar level.
AKYA was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-25 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2025-03-18 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-11-19 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-15 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-06-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-14 | BTIG | Maintains | Buy -> Buy |
| 2024-05-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Neutral |
| 2023-11-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-08-08 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-08-08 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-03-21 | Stephens & Co. | Reiterate | Overweight |
| 2023-03-08 | Morgan Stanley | Maintains | Overweight |